Skip to main content
SpringerLink
Log in

Hirudin

the next cardiovascular blockbuster?

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Hirudin could well be the next blockbuster in the cardiovascular pharmaceutical market if discussions at the recent 66th Scientific Sessions of the American Heart Association are anything to go by. This new antithrombotic was the focus of many discussions and presented abstracts at the meeting, which was held in Atlanta, US, in November.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Nicola Ryan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryan, N. Hirudin. Inpharma Wkly. 916, 3–4 (1993). https://doi.org/10.2165/00128413-199309160-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199309160-00005

Keywords

Search

Navigation